NovaBay Pharmaceuticals (NYSE:NBY) Earns Sell Rating from Analysts at StockNews.com

Equities researchers at StockNews.com began coverage on shares of NovaBay Pharmaceuticals (NYSE:NBY) in a research note issued to investors on Wednesday. The firm set a “sell” rating on the stock.

NovaBay Pharmaceuticals Stock Performance

NBY stock opened at $0.08 on Wednesday. The company’s 50-day moving average price is $0.12 and its 200 day moving average price is $0.20. NovaBay Pharmaceuticals has a 52 week low of $0.07 and a 52 week high of $1.28. The company has a market cap of $2.91 million, a P/E ratio of -0.02 and a beta of 1.97.

NovaBay Pharmaceuticals (NYSE:NBY) last issued its quarterly earnings data on Tuesday, March 26th. The company reported ($0.95) earnings per share (EPS) for the quarter. The firm had revenue of $3.73 million for the quarter. NovaBay Pharmaceuticals had a negative return on equity of 150.14% and a negative net margin of 65.46%. On average, equities research analysts expect that NovaBay Pharmaceuticals will post -0.41 earnings per share for the current year.

Institutional Inflows and Outflows

A hedge fund recently bought a new stake in NovaBay Pharmaceuticals stock. Armistice Capital LLC acquired a new position in shares of NovaBay Pharmaceuticals, Inc. (NYSE:NBY) during the 4th quarter, according to its most recent filing with the SEC. The institutional investor acquired 718,768 shares of the company’s stock, valued at approximately $147,000. Armistice Capital LLC owned 11.01% of NovaBay Pharmaceuticals at the end of the most recent reporting period. 23.25% of the stock is owned by institutional investors and hedge funds.

NovaBay Pharmaceuticals Company Profile

NovaBay Pharmaceuticals, Inc, a biopharmaceutical company, develops and sells eyecare, skincare, and wound care products in the United States and internationally. It offers Avenova Spray, a solution for removing foreign materials, including microorganisms and debris from skin around the eye, such as the eyelid; and wound care products, which are used for cleansing and irrigation as part of surgical procedures, as well as treating certain wounds, burns, ulcers, and other injuries under the NeutroPhase and PhaseOne brands.